What is the recommended dosage and usage of metaxalone and methocarbamol (muscle relaxants) for treating muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosage and Usage of Metaxalone and Methocarbamol for Muscle Spasms

Methocarbamol Dosing

For acute muscle spasms, methocarbamol should be initiated at 1500 mg four times daily (6 grams/day) for the first 48-72 hours, then reduced to a maintenance dose of 1000-1500 mg four times daily (4 grams/day). 1

  • The FDA-approved initial dosing is 1500 mg (two 750 mg tablets) four times daily for severe conditions, with up to 8 grams daily permissible during the acute phase (first 48-72 hours) 1
  • After the initial treatment period, dosage should be reduced to approximately 4 grams daily for maintenance 1
  • Alternative dosing: 1000 mg every 4 hours or 1500 mg three times daily for maintenance 1
  • Clinical trials demonstrated efficacy at 1500 mg four times daily, with approximately 60% of patients experiencing relief compared to 30% with placebo 2

Metaxalone Dosing

Metaxalone dosing information is limited in the provided evidence, but it should be held on the day of surgical procedures to avoid potentiating anesthetic agents. 3

  • The Mayo Clinic specifically recommends discontinuing metaxalone before surgery due to interaction risks with anesthetics 3
  • Metaxalone is contraindicated in patients with significant hepatic or renal dysfunction 3
  • Evidence suggests metaxalone has fewer reported side effects compared to other skeletal muscle relaxants, with no major safety issues documented 4

Duration of Treatment

Both agents should be used for short-term relief only, typically not exceeding 2-3 weeks. 5, 6

  • Systematic reviews support skeletal muscle relaxants only for short-term relief of acute low back pain when NSAIDs or acetaminophen are ineffective 6
  • Studies evaluating methocarbamol for acute low back pain showed 44% of patients achieved complete pain relief and discontinued treatment early (versus 18% with placebo) 7
  • Treatment should be discontinued as soon as pain-free state is achieved 7

Safety Considerations and Monitoring

Regular monitoring for central nervous system side effects is essential, as drowsiness and dizziness occur frequently with both agents. 8, 5, 6

Methocarbamol-Specific Precautions:

  • Common side effects include drowsiness, dizziness, bradycardia, and hypotension 8
  • Should be used with caution in patients undergoing surgery due to cardiovascular effects 8
  • Contraindicated in patients with myasthenia gravis and should be avoided in Parkinson's disease 8
  • Number needed to harm (NNTH) for adverse events is 3 (95% CI 2-7) based on trials lasting more than 24 hours 5

Metaxalone-Specific Precautions:

  • Must be held on day of surgery to prevent excessive sedation when combined with anesthetics 3
  • Contraindicated in significant hepatic or renal impairment 3
  • Has the fewest reports of side effects among commonly prescribed skeletal muscle relaxants 4

Comparative Effectiveness

No skeletal muscle relaxant has been proven superior to another, and choice should be based primarily on side-effect profile and patient-specific factors. 6

  • Comparison studies have not demonstrated superiority of one agent over another 6
  • Metaxalone and methocarbamol are less sedating than cyclobenzaprine, though effectiveness evidence for metaxalone is limited 6
  • Neither agent has been proven superior to acetaminophen or NSAIDs for low back pain 6

Clinical Pitfalls to Avoid

  • Do not use these agents as first-line therapy—they should only be considered when NSAIDs or acetaminophen are ineffective or not tolerated 6
  • Avoid prolonged use beyond 2-3 weeks—evidence supports only short-term efficacy 5, 6
  • Do not overlook cardiovascular monitoring with methocarbamol, particularly in surgical or perioperative settings 8
  • Always discontinue metaxalone before scheduled surgery to prevent dangerous interactions with anesthetics 3
  • Clearly communicate sedation risks to patients, as dizziness and drowsiness are consistently reported adverse effects that may impair driving and daily activities 5, 6

References

Guideline

Drug Interactions of Metaxalone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A review of three commonly prescribed skeletal muscle relaxants.

Journal of back and musculoskeletal rehabilitation, 2000

Research

Muscle relaxants for pain management in rheumatoid arthritis.

The Cochrane database of systematic reviews, 2012

Research

Choosing a skeletal muscle relaxant.

American family physician, 2008

Guideline

Methocarbamol Use in Patients Without Kidney or Liver Issues

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.